The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant and adjuvant nivolumab and lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck.
 
Glenn J. Hanna
Honoraria - Bristol-Myers Squibb; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Bicara Therapeutics; Bio-Rad; Bristol-Myers Squibb; Exicure; Kura Oncology; Maverick Therapeutics; Merck; Naveris; Prelude Therapeutics; Regeneron; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Conquer Cancer, the ASCO Foundation; Elevar Therapeutics (Inst); EMD Serono (Inst); Exicure (Inst); Gateway for Cancer Research; Genzyme (Inst); GlaxoSmithKline (Inst); Kartos Therapeutics (Inst); Kite/Gilead (Inst); NantKwest, (Inst); Regeneron (Inst); V Foundation
Expert Testimony - Aaronson Rappaport Feinstein & Deutsch
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Maverick Therapeutics; Regeneron
 
Anne M. O'Neill
No Relationships to Disclose
 
Vickie Y. Jo
No Relationships to Disclose
 
Kristine Wong
No Relationships to Disclose
 
Patrick H. Lizotte
Patents, Royalties, Other Intellectual Property - PCT/2018/041266
 
Donald J. Annino
No Relationships to Disclose
 
Laura A. Goguen
No Relationships to Disclose
 
Jason I. Kass
No Relationships to Disclose
 
Eleni M. Rettig
No Relationships to Disclose
 
Rosh K.V. Sethi
No Relationships to Disclose
 
Jochen H. Lorch
Consulting or Advisory Role - Bayer; Eisai; Genentech; Novartis
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst)
 
Jonathan D. Schoenfeld
Consulting or Advisory Role - ACI Clinical; Catenion; Debiopharm Group; Immunitas; LEK; Tilos Therapeutics
Research Funding - Bristol-Myers Squibb; Merck; Regeneron
Expert Testimony - Heidell, Pittoni, Murphy & Bach; Kline & Specter P.C.
 
Danielle N. Margalit
No Relationships to Disclose
 
Roy B. Tishler
No Relationships to Disclose
 
Peter C. Everett
No Relationships to Disclose
 
Anupam M. Desai
No Relationships to Disclose
 
Cloud P. Paweletz
Honoraria - AstraZeneca; Bio-Rad
Consulting or Advisory Role - DropWorks
Travel, Accommodations, Expenses - AstraZeneca
 
Ann Marie Egloff
No Relationships to Disclose
 
Ravindra Uppaluri
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Consulting or Advisory Role - Achilles Therapeutics; AstraZeneca; BioNTech; Bristol-Myers Squibb; Celgene; Eisai; EMD Serono; Genentech; Gilead Sciences; GlaxoSmithKline; Immunomic Therapeutics; Loxo; Merck; Pfizer; Vaccinex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst); VentiRx (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - ISA Pharmaceuticals; Nanobiotix